Moderna begins coronavirus vaccine trial
The US biotech Moderna was just about the only stock on the rise yesterday amid the global COVID-19 bear market, as the Massachusetts firm announced the first patient had been tested with its potential coronavirus vaccine. Moderna is focused on development of vaccines based around mRNA, which...
pharmaphorum.com